SCHEMBL6958304

SCHEMBL6958304

CS(=O)(=O)O[C@H]1CCc2ccc(F)cc2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 2/20 0.39
HTR1B P28222 1/20 0.39
PSEN1 P49768 2/20 0.39
PSEN2 P49810 2/20 0.39
APH1B Q8WW43 2/20 0.39
NCSTN Q92542 2/20 0.39
APH1A Q96BI3 2/20 0.39
PSENEN Q9NZ42 2/20 0.39
SRD5A1 P18405 4/20 0.38
DRD2 P14416 2/20 0.37
DRD3 P35462 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
ACHE P22303 2/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
SLC6A4 P31645 1/20 0.35
TSHR P16473 2/20 0.35
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6951811 1.00 HTR1D (0.39) HTR1DHTR1BPSEN1PSEN2APH1B
SCHEMBL6951816 1.00 HTR1D (0.39) HTR1DHTR1BPSEN1PSEN2APH1B
SCHEMBL6957838 0.94 HTR1D (0.45) HTR1DHTR1BPSEN1PSEN2APH1B
SCHEMBL6957834 0.94 HTR1D (0.45) HTR1DHTR1BPSEN1PSEN2APH1B
SCHEMBL6958050 0.94 HTR1D (0.45) HTR1DHTR1BPSEN1PSEN2APH1B
SCHEMBL6951218 0.83 HDAC8 (0.32) DRD2DRD3HDAC8ACHECA1
SCHEMBL6405616 0.82 DRD2 (0.57) DRD2DRD3ACHECA1CA2
SCHEMBL6953263 0.80 CA1 (0.45) CA1CA2SLC6A4MTNR1AMTNR1B
SCHEMBL4857120 0.80 CA1 (0.45) CA1CA2SLC6A4MTNR1AMTNR1B
SCHEMBL6954469 0.78 EPAS1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0757677-B1 BENZOCYCLOHEXYLIMIDAZOLETHIONE DERIVATIVES SYNTEX LLC (US) 2003-06-18 EP disclosed
US-5719280-A REACTING AMINE SUBSTITUTED BENZOCYCLOALKANE WITH DIALKYLOXYACETALDEHYDE IN PRESENCE OF REDUCING AGENT OR CATALYTIC HYDROGENATION, TREATING WITH THIOCYANIC ACID SYNTEX (U.S.A.) INC. (US) 1998-02-17 US disclosed
EP-0757677-A1 BENZOCYCLOALKYLAZOLETHIONE DERIVATIVES SYNTEX (U.S.A.) INC. (US) 1997-02-12 EP disclosed
US-5538988-A CARDIOVASCULAR DISORDERS AND DOPAMINE HYDROLASE ENZYME INHIBITORS SYNTEX (U.S.A.) INC. 1996-07-23 US disclosed
WO-1995029165-A2 BENZOCYCLOALKYLAZ0LETHIONE DERIVATIVES AS DOPAMIN BETA-HYDROXYLASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1995-11-02 WO disclosed